FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / BMC Vet Res / Extracellular matrix remodeling in equine sarcoid: an immuno...
BMC veterinary research2016; 12; 24; doi: 10.1186/s12917-016-0648-1

Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study.

Abstract: Equine sarcoids are locally invasive, fibroblastic benign skin tumors. Bovine papillomavirus type-1 (BPV-1) and/or Bovine papillomavirus type-2 (BPV-2) are believed to be the causative agent of sarcoids, although the mechanisms by which the virus induce the tumor are still poorly understood. We hypothesized that in genetically predisposed equines latent BPV infection may be reactivated by immunosoppression and/or mechanical injury leading to a form of pathologic wound which may transform into a sarcoid. In this study, we investigated in 25 equine sarcoids and in five normal skin samples the histological features and evaluated the immunohistochemical and molecular expression of type I and type III Collagen, vimentin (VIM), alfa Smooth Muscle Actin (α-SMA), Matrix Metalloproteinase (MMPs) -2, 9, 14 and tissue inhibitor of metalloproteinase 2 (TIMP-2). Results: In 64% of investigated sarcoids, type I collagen staining was stronger than that of type III collagen. In 80% of sarcoids, SFs were strongly positive for vimentin and negative for α-SMA; the remaining sarcoid samples (20%) showed 70-80% of SFs labeled for vim and approximately 20-30% labeled for α-SMA. Moreover, all sarcoid specimen showed a variable staining pattern (weak to moderate) for MMP-9 and MMP-14, and a moderate to strong staining for MMP-2 and TIMP-2. Biochemical analysis confirmed immunohistochemical results and showed in sarcoids, for the first time, the cleaved form of MMP9, the 35 KDa active species for MMP-9. Conclusions: This study revealed that in equine sarcoids exhibit an altered turnover of the Extracellular Matrix (ECM) deposition and degradation, as result of an altered expression of MMPs and TIMPs. Therefore, these observations seem to confirm that the basic mechanism for growth of equine sarcoids could be a neoplastic transformation during wound healing.
Get Full Text
Publication Date: 2016-02-02 PubMed ID: 26838095PubMed Central: PMC4736642DOI: 10.1186/s12917-016-0648-1Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the role of viruses and altered extracellular matrix turnover in causing equine sarcoids, a type of benign skin tumor in horses. The researchers proposed that sarcoids might result from a transformation during wound healing, examining the expression of collagens, vimentin, alpha Smooth Muscle Actin, Matrix Metalloproteinase, and Tissue Inhibitor of Metalloproteinase in 25 sarcoids and five normal skin samples.

Introduction and Hypothesis

  • The study begins with an exploration of equine sarcoids, fibroblastic benign skin tumors found in horses. Although the main cause for these tumors is believed to be Bovine papillomavirus type-1 (BPV-1) and/or type-2 (BPV-2), the exact mechanisms are not entirely understood.
  • The researchers hypothesized that these papillomaviruses might induce tumors in genetically predisposed horses, which could be reactivated by immunosuppression or mechanical injuries.
  • This hypothesis revolved around the concept that wounds might transform into sarcoids due to a pathological or abnormal healing process.

Research Method and Results

  • The research team examined 25 equine sarcoids and five normal skin samples, assessing the molecular expression of several proteins including type I and III Collagen, vimentin (VIM), alpha Smooth Muscle Actin (α-SMA), Matrix Metalloproteinase (MMPs) -2, 9, 14, and tissue inhibitor of metalloproteinase 2 (TIMP-2).
  • Results showed 64% of sarcoids had strong staining for type I collagen than type III, while 80% evidenced significant vimentin positivity and negligible α-SMA expression. The remaining 20% had 70-80% vimentin label and approximately 20-30% α-SMA label.
  • Furthermore, all sarcoid samples demonstrated variable staining for MMP-9 and MMP-14, and moderate to strong staining for MMP-2 and TIMP-2. Biochemical analysis revealed the cleaved form of MMP9, the 35 KDa active species for MMP-9.

Conclusions

  • Findings indicated that equine sarcoids have a disrupted turnover of the Extracellular Matrix (ECM) due to altered expression of MMPs and TIMPs.
  • The researchers inferred that this disrupted ECM turnover is a likely reason for the growth of equine sarcoids, affirming their hypothesis that a pathological transformation during the process of wound healing leads to the production of these skin tumors.

Cite This Article

APA
Martano M, Corteggio A, Restucci B, De Biase ME, Borzacchiello G, Maiolino P. (2016). Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study. BMC Vet Res, 12, 24. https://doi.org/10.1186/s12917-016-0648-1

Publication

BMC veterinary research
ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 12
Pages: 24

Researcher Affiliations

Martano, Manuela
  • Department of Veterinary Medicine and Animal Productions, Naples University "Federico II", Via F. Delpino 1, 80137, Naples, Italy. manuela.martano@unina.it.
Corteggio, Annunziata
  • Present Address: Institute of Protein Biochemistry (IBP) National Research Council (CNR), Via Pietro Castellino 111, 80131, Naples, Italy. a.corteggio@ibp.cnr.it.
Restucci, Brunella
  • Department of Veterinary Medicine and Animal Productions, Naples University "Federico II", Via F. Delpino 1, 80137, Naples, Italy. restucci@unina.it.
De Biase, Maria Ester
  • Department of Veterinary Medicine and Animal Productions, Naples University "Federico II", Via F. Delpino 1, 80137, Naples, Italy. mariu12@hotmail.it.
Borzacchiello, Giuseppe
  • Department of Veterinary Medicine and Animal Productions, Naples University "Federico II", Via F. Delpino 1, 80137, Naples, Italy. giuseppe.borzacchiello@unina.it.
Maiolino, Paola
  • Department of Veterinary Medicine and Animal Productions, Naples University "Federico II", Via F. Delpino 1, 80137, Naples, Italy. maiolino@unina.it.

MeSH Terms

  • Animals
  • Extracellular Matrix / metabolism
  • Extracellular Matrix / pathology
  • Horse Diseases / metabolism
  • Horse Diseases / pathology
  • Horses
  • Matrix Metalloproteinase Inhibitors / metabolism
  • Matrix Metalloproteinases / metabolism
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology
  • Skin Neoplasms / veterinary
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism

References

This article includes 48 references
  1. Borzacchiello G, Corteggio A. Equine sarcoid: state of the art.. Ippologia 2009;20:7–14.
  2. Nasir L, Brandt S. Papillomavirus associated diseases of the horse.. Vet Microbiol 2013;167(Suppl 1–2):159–67.
    pubmed: 24016387
  3. Torrontegui BO, Reid SJ. Clinical and pathological epidemiology of the equine sarcoid in a referral population.. Eq Vet Educ 1994;6:85–8.
    doi: 10.1111/j.2042-3292.1994.tb01098.xgoogle scholar: lookup
  4. Nasir L, Campo MS. Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids.. Vet Dermatol 2008;19:243–54.
    doi: 10.1111/j.1365-3164.2008.00683.xpubmed: 18927950google scholar: lookup
  5. Knottenbelt DC. A suggested clinical classification of the equine sarcoid.. Clin Tech in Eq Pract 2005;4:278–95.
    doi: 10.1053/j.ctep.2005.10.008google scholar: lookup
  6. Tarwid JN, Fretz PB, Clark EG. Equine sarcoids: A study with emphasis on pathological diagnosis.. Compend Contin Educ 1985;7:293–300.
  7. Martens A, De Moor A, Demeulemeester J, Peelman L. Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA.. Vet Surg 2001;30:460–7.
    doi: 10.1053/jvet.2001.25874pubmed: 11555822google scholar: lookup
  8. Yuan Z, Gobeil PA, Campo MS, Nasir L. Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive.. Virol 2010;396:143–51.
    doi: 10.1016/j.virol.2009.10.010pubmed: 19896685google scholar: lookup
  9. Mosseri S, Hetzel U, Hahn S, Michaloupoulou E, Sallabank HC, Knottenbelt DC. Equine sarcoid: In situ demonstration of matrix metalloproteinase expression.. Vet J 2014;202(Suppl.2):279–85.
    doi: 10.1016/j.tvjl.2014.07.026pmc: PMC7128672pubmed: 25439440google scholar: lookup
  10. Chambers G, Ellsmore VA, O’Brien PM, Reid SWJ, Love S, Campo MS. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids.. Virus Res 2003;96(Suppl 1–2):141–5.
    pubmed: 12951274
  11. Martens A, Moor ADE, Demeulemeester J, Ducatelle R. Histopathological characteristics of five clinical types of equine sarcoid.. Res Vet Sci 2000;69(Suppl3):295–300.
    pubmed: 11124103
  12. Cochrane AC. Models in vivo of wound healing in the horse and the role of growth factors.. Vet Dermatol 1997;8:259–72.
    pubmed: 34645018
  13. Hansen RR. Complications of EquineWound Management and Dermatologic Surgery.. Vet Clin Eq 2009;24:663–96.
    doi: 10.1016/j.cveq.2008.10.005pubmed: 19203707google scholar: lookup
  14. Haddow A. Molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing?. Adv Cancer Res 1972;16:181–234.
    doi: 10.1016/S0065-230X(08)60341-3pubmed: 4563044google scholar: lookup
  15. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.. N Engl J Med 1986;315:1650–9.
    doi: 10.1056/NEJM198612253152606pubmed: 3537791google scholar: lookup
  16. Schäfer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited.. Nat Rev Mol Cell Biol 2008;9(Suppl. 8):628–38.
    doi: 10.1038/nrm2455pubmed: 18628784google scholar: lookup
  17. Imaizumi R, Akasaka Y, Inomata N, Okada E, Ito K, Ishikawa Y. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.. Histopathol 2009;54(Suppl.6):722–30.
    doi: 10.1111/j.1365-2559.2009.03287.xpubmed: 19438747google scholar: lookup
  18. Pilcher BK, Dumin JA, Sí¯¬k BD, Krane SM, Welgus HG, Parks WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix.. J Cell Biol 1997;137:1445–57.
    doi: 10.1083/jcb.137.6.1445pmc: PMC2132537pubmed: 9182674google scholar: lookup
  19. Allen DL, Teitelbaum DH, Kurachi K. Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro.. Am J Physiol Cell Physiol 2003;284 Suppl 4:C805–15.
    pubmed: 12466149
  20. Giantin M, Aresu L, Benali S, Aricò A, Morello EM, Martano M. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.. J Comp Pathol 2012;147 Suppl 4:419–29.
    pubmed: 22520817
  21. Osenkowski P, Toth M, Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).. J Cell Physiol 2004;200 Suppl 1:2–10.
    pubmed: 15137052
  22. Borzacchiello G, Mogavero S, De Vita G, Roperto S, Della Salda L, Roperto F. Activated platelet-derived growth factor beta receptor expression, PI3K-AKT pathway molecular analysis, and transforming signals in equine sarcoids.. Vet Pathol 2009;46 Suppl 4:589–97.
    pubmed: 19276057
  23. Brandt S, Tober R, Corteggio A, Burger S, Sabitzer S, Walter I. BPV-1 infection is not confined to the dermis but also involves the epidermis of equine sarcoids.. Vet Microbiol 2011;150(Suppl 1–2):35–40.
    pubmed: 21242040
  24. Chambers G, Ellsmore VA, O’Brien PM, Reid SW, Love S, Campo MS. Association of bovine papillomavirus with the equine sarcoid.. J Gen Virol 2003;84:1055–62.
    doi: 10.1099/vir.0.18947-0pubmed: 12692268google scholar: lookup
  25. Martens A, De Moor A, Ducatelle R. PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids.. Vet J 2001;161:280–6.
    doi: 10.1053/tvjl.2000.0524pubmed: 11352485google scholar: lookup
  26. Otten N, von Tscharner C, Lazary S, Antczak DF, Gerber H. DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing.. Arch Virol 1993;132:121–31.
    doi: 10.1007/BF01309847pubmed: 8394687google scholar: lookup
  27. Reid SW, Smith KT, Jarrett WF. Detection, cloning and characterisation of papillomaviral DNA present in sarcoid tumours of Equus asinus.. Vet Rec 1994;135:430–2.
    doi: 10.1136/vr.135.18.430pubmed: 7846835google scholar: lookup
  28. Borzacchiello G, Russo V, Della Salda L, Roperto S, Roperto F. Expression of platelet-derived growth factor-b receptor and bovine papillomavirus E5 and E7 oncoproteins in equine sarcoid.. J Comp Pathol 2008;139:231–7.
    doi: 10.1016/j.jcpa.2008.07.006pubmed: 18814884google scholar: lookup
  29. Carr EA, Théon AP, Madewell BR, Griffey SM, Hitchcock ME. Bovine papillomavirus DNA in neoplastic and non-neoplastic tissues obtained from horses with and without sarcoids in the western United States.. Am J Vet Res 2001;62:741–4.
    doi: 10.2460/ajvr.2001.62.741pubmed: 11341396google scholar: lookup
  30. Nasir L, Reid SW. Bovine papillomaviral gene expression in equine sarcoid tumours.. Virus Res 1999;61:171–5.
    doi: 10.1016/S0168-1702(99)00022-2pubmed: 10475087google scholar: lookup
  31. Ragland WL, Spencer GR. Attempts to relate bovine papillomavirus to the cause of equine sarcoid: Equidae inoculated intradermally with bovine papillomavirus.. Am J Vet Res 1969;30:743–52.
    pubmed: 5813668
  32. Yuan ZQ, Gault EA, Gobeil P, Nixon C, Campo MS, Nasir L. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.. Virol 2008;373:352–61.
    doi: 10.1016/j.virol.2007.11.037pubmed: 18191170google scholar: lookup
  33. Bogaert L, Martens A, De Baere C, Gasthuys F. Detection of bovine papillomavirus DNA on the normal skin and in the habitual surroundings of horses with and without equine sarcoids.. Res Vet Sci 2005;79 Suppl 3:253–8.
    pubmed: 16054896
  34. Yuan ZQ, Philbey AW, Gault EA, Campo MS, Nasir L. Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions.. Virus Res 2007;124(Suppl1-2):245–9.
    pubmed: 17140693
  35. Wobeser BK, Hill JE, Jackson ML, Kidney BA, Mayer MN, Townsend HG. Localization of Bovine papillomavirus in equine sarcoids and inflammatory skin conditions of horses using laser microdissection and two forms of DNA amplification.. J Vet Diagn Invest 2012;24 Suppl 1:32–41.
    pubmed: 22362933
  36. Williams IF, Heaton A, McCullagh KG. Connective tissue composition of the equine sarcoid.. Eq Vet J 1982;14 Suppl 4:305–10.
    pubmed: 7173140
  37. Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: Current concepts of pathogenesis (Review). Int J Mol Med 2009;24:283–293.
    doi: 10.3892/ijmm_00000231pubmed: 19639219google scholar: lookup
  38. Theoret CL, Olutoye OO, Parnell LK, Hicks J. Equine exuberant granulation tissue and human keloids: a comparative histopathologic study.. Vet Surg 2013;42 Suppl 7:783–9.
    pubmed: 24015864
  39. Ries C, Pitsch T, Mentele R, Zahler S, Egea V, Nagase H. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukemic cells: (auto-) catalytic activation and resistance to inhibition by TIMP-1.. Biochem J 2007;405(Suppl3):547–58.
    pmc: PMC2267301pubmed: 17489740
  40. Mohan R, Chintala SK, Jung JC, Villar W, McCabe F, Russo L. Matrix metalloproteinase gelatinase B (MMP-9) regulates and effects epithelial regeneration.. J Biol Chem 2002;277:2065–72.
    doi: 10.1074/jbc.M107611200pubmed: 11689563google scholar: lookup
  41. O’Toole EA, van Koningsveld R, Chen M, Woodley DT. Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway.. J Cell Physiol 2008;214 Suppl 1:47–55.
    pubmed: 17559070
  42. Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases.. Amino Acids 2011;41(Suppl2):271–90.
    pmc: PMC3102199pubmed: 20640864
  43. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment.. J Am Coll Surg 2008;206 Suppl 4:731–41.
    pubmed: 18387480
  44. Bergvall KE. Sarcoids.. Vet Clin North Am Eq Pract 2013;29(Suppl3):657–71.
    pubmed: 24267682
  45. Pascoe RR, Knottenbelt DC. Manual of Eq Dermatol pub.. London: WB Saunders; 1999. pp. 244–250.
  46. Restucci B, Martano M, Maiolino P. Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours.. Res Vet Sci 2015;100:182–8.
    doi: 10.1016/j.rvsc.2015.03.008pubmed: 25816929google scholar: lookup
  47. Martano M, Carella F, Squillacioti C, Restucci B, Mazzotta M, Lo Muzio L. Metallothionein expression in canine cutaneous apocrine gland tumors.. Anticancer Res 2012;32 Suppl 3:747–52.
    pubmed: 22399587
  48. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases.. Anal Biochem 1994;218(2):325–329.
    doi: 10.1006/abio.1994.1186pubmed: 8074288google scholar: lookup

Citations

This article has been cited 13 times.
  1. Zivelonghi G, Melotti L, Carolo A, Venerando A, Roncoroni M, Martinelli G, Maccatrozzo L, Marzorati S, Sugni M, Patruno M. Sea food by-products valorization for biomedical applications: evaluation of their wound regeneration capabilities in an Ex vivo skin model. Front Vet Sci 2024;11:1491385.
    doi: 10.3389/fvets.2024.1491385pubmed: 39660177google scholar: lookup
  2. Monod A, Koch C, Jindra C, Haspeslagh M, Howald D, Wenker C, Gerber V, Rottenberg S, Hahn K. CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts. Viruses 2023 Sep 17;15(9).
    doi: 10.3390/v15091942pubmed: 37766348google scholar: lookup
  3. Semik-Gurgul E, Gurgul A, Szmatoła T. Transcriptome and methylome sequencing reveals altered long non-coding RNA genes expression and their aberrant DNA methylation in equine sarcoids. Funct Integr Genomics 2023 Aug 8;23(3):268.
    doi: 10.1007/s10142-023-01200-2pubmed: 37552338google scholar: lookup
  4. Daraban Bocaneti F, Altamura G, Corteggio A, Tanase OI, Dascalu MA, Pasca SA, Hritcu O, Mares M, Borzacchiello G. Expression of collagenases (matrix metalloproteinase-1, -8, -13) and tissue inhibitor of metalloproteinase-3 (TIMP-3) in naturally occurring bovine cutaneous fibropapillomas. Front Vet Sci 2022;9:1072672.
    doi: 10.3389/fvets.2022.1072672pubmed: 36713871google scholar: lookup
  5. Daraban Bocaneti F, Altamura G, Corteggio A, Tanase OI, Dascalu MA, Pasca SA, Hritcu O, Mares M, Borzacchiello G. Expression of matrix metalloproteinases (MMPs)-2/-7/-9/-14 and tissue inhibitors of MMPs (TIMPs)-1/-2 in bovine cutaneous fibropapillomas associated with BPV-2 infection. Front Vet Sci 2022;9:1063580.
    doi: 10.3389/fvets.2022.1063580pubmed: 36518899google scholar: lookup
  6. Podstawski P, Ropka-Molik K, Semik-Gurgul E, Samiec M, Skrzyszowska M, Podstawski Z, Szmatoła T, Witkowski M, Pawlina-Tyszko K. Tracking the Molecular Scenarios for Tumorigenic Remodeling of Extracellular Matrix Based on Gene Expression Profiling in Equine Skin Neoplasia Models. Int J Mol Sci 2022 Jun 10;23(12).
    doi: 10.3390/ijms23126506pubmed: 35742950google scholar: lookup
  7. Podstawski P, Ropka-Molik K, Semik-Gurgul E, Samiec M, Skrzyszowska M, Podstawski Z, Szmatoła T, Witkowski M, Pawlina-Tyszko K. Assessment of BPV-1 Mediated Matrix Metalloproteinase Genes Deregulation in the In Vivo and In Vitro Models Designed to Explore Molecular Nature of Equine Sarcoids. Cells 2022 Apr 8;11(8).
    doi: 10.3390/cells11081268pubmed: 35455948google scholar: lookup
  8. Martano M, Altamura G, Power K, Liguori P, Restucci B, Borzacchiello G, Maiolino P. Beclin 1, LC3 and P62 Expression in Equine Sarcoids. Animals (Basel) 2021 Dec 23;12(1).
    doi: 10.3390/ani12010020pubmed: 35011126google scholar: lookup
  9. Altamura G, Martano M, Licenziato L, Maiolino P, Borzacchiello G. Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection. Front Vet Sci 2020;7:148.
    doi: 10.3389/fvets.2020.00148pubmed: 32292795google scholar: lookup
  10. Martano M, Altamura G, Power K, Restucci B, Carella F, Borzacchiello G, Maiolino P. Evaluation of Hypoxia-Inducible Factor-1 Alpha (HIF-1α) in Equine Sarcoid: An Immunohistochemical and Biochemical Study. Pathogens 2020 Jan 14;9(1).
    doi: 10.3390/pathogens9010058pubmed: 31947661google scholar: lookup
  11. Martano M, Power K, Restucci B, Pagano I, Altamura G, Borzacchiello G, Maiolino P. Expression of vascular endothelial growth factor (VEGF) in equine sarcoid. BMC Vet Res 2018 Sep 3;14(1):266.
    doi: 10.1186/s12917-018-1576-zpubmed: 30176852google scholar: lookup
  12. He Y, Tan X, Hu H, Wang Q, Hu X, Cai X, Guan Y, Chen B, Jing X. Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway. Oncol Lett 2018 Mar;15(3):2939-2945.
    doi: 10.3892/ol.2017.7699pubmed: 29435022google scholar: lookup
  13. Araldi RP, Assaf SMR, Carvalho RF, Carvalho MACR, Souza JM, Magnelli RF, Módolo DG, Roperto FP, Stocco RC, Beçak W. Papillomaviruses: a systematic review. Genet Mol Biol 2017 Jan-Mar;40(1):1-21.
    doi: 10.1590/1678-4685-GMB-2016-0128pubmed: 28212457google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.